BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32535819)

  • 1. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
    Motegi K; Matsutomo N; Yamamoto T; Koizumi M
    Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bone metastatic burden by bone SPECT/CT in metastatic prostate cancer patients: defining threshold value for total bone uptake and assessment in radium-223 treated patients.
    Umeda T; Koizumi M; Fukai S; Miyaji N; Motegi K; Nakazawa S; Takiguchi T
    Ann Nucl Med; 2018 Feb; 32(2):105-113. PubMed ID: 29243019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative bone SPECT/CT: high specificity for identification of prostate cancer bone metastases.
    Tabotta F; Jreige M; Schaefer N; Becce F; Prior JO; Nicod Lalonde M
    BMC Musculoskelet Disord; 2019 Dec; 20(1):619. PubMed ID: 31878904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
    Ichikawa H; Shibutani T; Onoguchi M; Taniguchi Y
    Ann Nucl Med; 2022 Nov; 36(11):941-950. PubMed ID: 36048347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative evaluation of anti-resorptive agent-related osteonecrosis of the jaw using bone single photon emission computed tomography in clinical settings: relationship between clinical stage and imaging.
    Okui T; Kobayashi Y; Tsujimoto M; Satoh K; Toyama H; Matsuo K
    Ann Nucl Med; 2020 Sep; 34(9):620-628. PubMed ID: 32557015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of quantitative bone SPECT/CT for medication-related osteonecrosis of the jaw in clinical settings.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2022 May; 40(5):492-499. PubMed ID: 34851501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative assessment of
    Oya T; Ichikawa Y; Nakamura S; Tomita Y; Sasaki T; Inoue T; Sakuma H
    Ann Nucl Med; 2023 Jun; 37(6):360-370. PubMed ID: 36947324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients.
    Mohd Rohani MF; Mat Nawi N; Shamim SE; Wan Sohaimi WF; Wan Zainon WMN; Musarudin M; Said MA; Hashim H
    Ann Nucl Med; 2020 Jan; 34(1):39-48. PubMed ID: 31612417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative [
    Tanaka K; Norikane T; Mitamura K; Yamamoto Y; Maeda Y; Fujimoto K; Takami Y; Ishimura M; Arai-Okuda H; Tohi Y; Kudomi N; Sugimoto M; Nishiyama Y
    EJNMMI Phys; 2022 Dec; 9(1):83. PubMed ID: 36469149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
    Zhang Y; Li B; Yu H; Song J; Zhou Y; Shi H
    Nucl Med Commun; 2021 Jan; 42(1):63-67. PubMed ID: 33044406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative bone SPECT/CT applications for cartilaginous bone neoplasms.
    Kitajima K; Futani H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
    Hell J Nucl Med; 2020; 23(2):133-137. PubMed ID: 32716404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative bone SPECT/CT applications for primary bone neoplasms.
    Kitajima K; Futani H; Komoto H; Tsuchitani T; Takahashi Y; Tachibana T; Yamakado K
    Hell J Nucl Med; 2021; 24(1):36-44. PubMed ID: 33866337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of two-dimensional total bone uptake (2D-TBU) and bone scan index (BSI) extracted from active bone metastatic burden on the bone scintigraphy in patients with radium-223 treatment.
    Fukai S; Daisaki H; Umeda T; Shimada N; Terauchi T; Koizumi M
    Ann Nucl Med; 2024 Jun; 38(6):450-459. PubMed ID: 38517659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.
    Bando R; Otsuka H; Otani T; Matsuda N; Azane S; Kunikane Y; Otomi Y; Sako W; Izumi Y; Harada M
    Ann Nucl Med; 2021 Apr; 35(4):504-513. PubMed ID: 33630226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of quantitative bone SPECT/CT for evaluating medication-related osteonecrosis of the jaw treatment response.
    Moridera K; Kitajima K; Yoshikawa K; Takaoka K; Tsuchitani T; Noguchi K; Kishimoto H; Yamakado K
    Jpn J Radiol; 2023 Jul; 41(7):760-767. PubMed ID: 36656541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of the Prostate Cancer Bone Metastases: Is It Feasible to Compare 18F-fluorocholine PET/CT, 18F-fluorodeoxyglucose PET/CT and 99mTc-methyl Diphosphonate Bone Scintigraphy?
    Pietrzak AK; Czepczynski R; Wierzchoslawska E; Cholewinski W
    Urol J; 2018 Sep; 15(5):242-247. PubMed ID: 29681049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative SPECT/CT imaging for medication-related osteonecrosis of the jaw: a preliminary study using volume-based parameters, comparison with chronic osteomyelitis.
    Ogura I; Kobayashi E; Nakahara K; Igarashi K; Haga-Tsujimura M; Toshima H
    Ann Nucl Med; 2019 Oct; 33(10):776-782. PubMed ID: 31342316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer.
    Kuji I; Yamane T; Seto A; Yasumizu Y; Shirotake S; Oyama M
    Eur J Hybrid Imaging; 2017; 1(1):2. PubMed ID: 29782587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardized Uptake Value from Semiquantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography in Normal Thoracic and Lumbar Vertebrae of Breast Cancer Patients.
    Rohani MFM; Yonan SNM; Tagiling N; Zainon WMNW; Udin Y; Nawi NM
    Asian Spine J; 2020 Oct; 14(5):629-638. PubMed ID: 32213791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.